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Anemia of chronic kidney disease (CKD) is attributed to a decreased production 
of erythrocytes due to a deficiency in erythropoietin (EPO). Administration of EPO is 
used to reduce anemia in these patients. However, CKD erythrocytes show higher 
rigidity and reduced half-life, which also contributes to anemia [1]. Factors influencing 
survival of diseased erythrocytes have been investigated but final conclusions cannot be 
stated. We hypothesize that the membrane structure may play a role in their flexibility 
and we investigate possible differences in their membrane proteome by DIGE 
technology. 
Three groups were investigated (four individuals per group): control, nonEPO-
treated CKD stage V and EPO-treated CKD patients (dialyzed). Erythrocytes were 
isolated from plasma, washed three times and lysed in a total of five cycles to isolate the 
membrane fraction. Membrane proteins were solubilized in 7M urea, 2M thiourea, 4% 
CHAPS and purified on chromatographic minicolumns prior to CyDye DIGE fluor 
saturation labelling [2]. 
The DIGE analysis resulted in a total of 760 detected spots, on average, and 420 
spots matched throughout all gels. 33 spots were differentially expressed (p<0,05) 
between at least two of the three groups investigated. PCA analysis confirmed adequate 
grouping of the samples and clearly differentiates nonEPO-treated CKD patients from 
the other two groups. Nine differential spots could be identified corresponding to beta-
adducin, HSP71/72 and tropomodulin-1. Ezrin, radixin and moesin were also identified 
but  based on peptide sequences which were identical for the three proteins. So, it was 
not possible to unequivocally attribute significant differences to any of them by mass 
spectrometry. By WB analysis, we confirmed ezrin and radixin as overexpressed in 
EPO-treated CKD patients, while moesin could not be detected. 
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